Format

Send to

Choose Destination
Am J Public Health. 2009 Feb;99(2):221-7. doi: 10.2105/AJPH.2007.131714. Epub 2008 Sep 17.

The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

Author information

1
Stone Mountain Health Services, St Charles Clinic, St Charles, VA 24282, USA. artvanzee@adelphia.net

Abstract

I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of controlled drugs by the pharmaceutical industry and an enhanced capacity of the Food and Drug Administration to regulate and monitor such promotion can have a positive impact on the public health.

PMID:
18799767
PMCID:
PMC2622774
DOI:
10.2105/AJPH.2007.131714
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center